AlphaYouTG
Schedule 13D filing
TPG GP A, LLC cut its Allogene Therapeutics, Inc. (ALLO) stake below 5%
TPG GP A, LLC reported owning 0% of Allogene Therapeutics, Inc. (ALLO) in a Schedule 13D filed Sep 30, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 30, 2026
- Source
- Schedule 13D
More ALLO insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.